Related Experiment Video
Updated: Jun 4, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition
Published on: January 7, 2019
MiniSOX9, a dominant-negative variant in colon cancer cells
R Abdel-Samad1, H Zalzali, C Rammah
1Institut de Génomique Fonctionnelle, Montpellier, France.
Abstract:
Inherited and acquired changes in pre-mRNA processing have significant roles in human diseases, especially cancer. Characterization of aberrantly spliced mRNAs may thus contribute to understand malignant transformation. We recently reported an anti-oncogenic potential for the SOX9 transcription factor in the colon. For instance, the Sox9 gene knock out in the mouse intestine results in an excess of proliferation with appearance of hyperplasia. SOX9 is expressed in colon cancer cells but its endogenous activity is weak. We looked for SOX9 variants that may impair SOX9 activity in colon cancer cells and we discovered MiniSOX9, a truncated version of SOX9 devoid of transactivation domain as a result of retention of the second intron. A significant overexpression of MiniSOX9 mRNA in human tumor samples compared with their matched normal tissues was observed by real-time reverse transcriptase-PCR. Immunohistochemistry revealed that MiniSOX9 is expressed at high levels in human colon cancer samples whereas it is undetectable in the surrounding healthy tissues. Finally, we discovered that MiniSOX9 behaves as a SOX9 inhibitor, inhibits protein kinase Cα promoter activity and stimulates the canonical Wnt pathway. This potential oncogenic activity of the SOX9 locus gives new insights on its role in colon cancer.
Insights
A novel truncated SOX9 variant, MiniSOX9, is overexpressed in colon cancer, inhibiting SOX9
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Aberrant pre-mRNA processing is implicated in human diseases, particularly cancer.
- The SOX9 transcription factor exhibits anti-oncogenic properties in the colon, with its knockout leading to intestinal hyperplasia.
- SOX9 activity is often diminished in colon cancer cells, suggesting the presence of inhibitory variants.
Purpose of the Study:
- To identify SOX9 variants that impair SOX9 activity in colon cancer cells.
- To investigate the role of a newly discovered truncated SOX9 variant, MiniSOX9, in colon cancer development.
Main Methods:
- Real-time reverse transcriptase-PCR to quantify MiniSOX9 mRNA levels in tumor and normal tissues.
- Immunohistochemistry to assess MiniSOX9 protein expression in colon cancer samples.
- Functional assays to determine MiniSOX9's effect on SOX9 activity, protein kinase Cα promoter, and Wnt pathway.
Main Results:
- A truncated SOX9 variant, MiniSOX9, resulting from intron retention, was identified.
- MiniSOX9 mRNA and protein were significantly overexpressed in human colon tumors compared to normal tissues.
- MiniSOX9 functions as a SOX9 inhibitor, represses protein kinase Cα promoter activity, and activates the canonical Wnt pathway.
Conclusions:
- MiniSOX9 is an oncogenic variant of SOX9 implicated in colon cancer progression.
- The overexpression of MiniSOX9 contributes to colon tumorigenesis by inhibiting SOX9 and activating oncogenic pathways.
- These findings offer new insights into the dual role of the SOX9 locus in colon cancer.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
MicroRNAs
MicroRNAs

